Clinical Consequences of Isolating the Gene for Huntington's Disease
BMJ 307:397-398, Harper,P.S., 1993
Ethical, Palliative, and Policy Considerations in Disorders of Consciousness
Neurol 91:471-475, Fins, J.J. & Bernat, J.L., 2018
"Undiagnosing" Multiple Sclerosis
Neurol 78:1986-1991,1904, Solomon, A.J.,et al, 2012
An Update on Brain Death Criteria A Simple Algorithm with Complex Questions
The Neurologist 17-237-240, Scripko, P.D.,et al, 2011
Huntingtons Disease
BMJ 341:34-40, Novak,M.J. &Tabrizi,S.J., 2010
Chronic Disorders of Consciousness
Lancet 367:1181-1192, Bernat,J.L., 2006
Prenatal Diagnosis Requests for Huntington's Disease when the Father is at Risk, and Does Not Want to Know His Genetic Status: Clinical, Legal, and Ethical Viewpoints
BMJ 326:331-333, Tassicker,R.,et al, 2003
Should Asymptomatic Patients with Hereditary Haemorrhagic Telangiectasia (HHT) be Screened for Cerebral Vascular Malformations? Data from 22 061 years of HHT Patient Life
JNNP 74:743-748, Easey,A.J.,et al, 2003
ALS Patients on TPPV
Neurol 61:135-137, Hayashi,H. &Oppenheimer,E.A., 2003
Euthanasia and Physician-Assisted Suicide Among Patients with Amyotrophic Lateral Sclerosis in the Netherlands
NEJM 346:1638-1644, Veldink,J.H.,et al, 2002
Ethical Considerations for Neurologist in the Management of Chronic Pain
Neurol 57:2166-2167, American academy of Neurology Ethics, Law and Huma, 2001
The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective
JAMA 277:832-836, Post,S.G.,et al, 1997
Genetic Testing for Alzheimer Disease, Practical and Ethical Issues
Arch Neurol 54:1226-1229, Roses,A.D., 1997
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Three Get Ready
Arch Neurol 53:1222-1223, Goldblatt,D., 1996
Withdrawing Artificial Feeding from Children with Brain Damage, Is Not the Same as Assisted Suicide or Euthanasia
BMJ 311:464-465, Cranford,R.E., 1995
The Use of Anencephalic Neonates as Organ Donors
Council on Ethical and Judicial Affairs, AMA, JAMA 273:1614-1618995., , 1995
Statement of Use of Apolipoprotein E Testing for Alzheimer Disease
JAMA 274:1627-1629, Farrer,L.A.,et al, 1995
Termination of Nutrition and Hydration in a Child with Vegetative State
Arch Pediatr Adolesc Med 148:87-92, Leicher,C.R.&DiMario,F.J., 1994
The Neurogenetic Genie:Testing for Huntington's Disease Mutation
Neurol 44:1369-1373, 1533-15361994., Hersch,S.,et al, 1994
Competent Pts with Adv States of Perm Paralysis Have the Right to Forgo Life-Sustaining Therapy
Neurol 43:224-225, Bernat,J.L.,et al, 1993
Persistent Vegetative State
ANA Comm on Ethical Affairs, Ann Neurol 33:386-390, 391993., , 1993
Attitudes Toward Direct Predictive Testing for the Huntington Disease Gene
JAMA 270:2321-2325, Babul,R.,et al, 1993
Presymptomatic Testing for Huntington's Disease in the United Kingdom
BMJ 304:1593-1596, Tyler,A.,et al, 1992
The Older Driver, Clinical Assessment and Injury Prevention
Arch Int Med 152:735-740, Underwood,M., 1992
Withholding and Withdrawal of Life Support from the Critically Ill
NEJM 322:309-315, Smedira,N.G.,et al, 1990
The Infant with Anencephaly
Med Task Force on Anencephaly, NEJM 322:669-6741990., , 1990
Predictive Testing for Huntington's Disease, Progress and Problems
BMJ 298:404-405, 1989, Harper,P.S.&Morris,M.J., 1989
The Use of Anencephalic Infants as Organ Sources, A Critique
JAMA 261:1773-1781, Shewmon,D.A.,et al, 1989
Problems in Genetic Prediction for Huntington's Disease
Lancet 2:601-603, Morris,M.J.,et al, 1989
Adoption and Genetic Prediction for Huntington's Disease
Lancet 2:1069-1070, Morris,M.,et al, 1988